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Abstract 
Nanodiamonds (NDs), as a new member of the carbon nanoparticles family, have attracted 
more and more attention in biomedicine recently due to their excellent physical and chemical 
properties. This paper summarizes the main results from the in vitro and in vivo safety as-
sessments of NDs and reports the application of NDs in the development of drug delivery 
systems. In view of the NDs’ characteristics of easy formation of a porous cluster structure in 
solution, an adsorption model for a variety of functional molecules on the ND clusters is 
proposed, which provides new ideas for developing a novel smart drug with various features 
such as sustained-release, targeting, and fluorescence imaging. 
Key  words:  Nanodiamonds  (NDs),  biocompatibility,  drug  delivery  system,  adsorption  model, 
versatility. 
Introduction 
Nanodiamonds (NDs) are carbon nanoparticles 
with a truncated octahedral architecture that are typ-
ically about 2 to 8 nm in diameter. They not only ex-
hibit  various  superior  characteristics  of  diamond, 
such as chemical stability, and extremely high hard-
ness,  stiffness  and  strength,  but  also  have  the  ad-
vantages of nanomaterials, such as small size, large 
surface area, and high adsorption capacity. Therefore, 
NDs have superior physical and chemical properties 
over conventional materials. Furthermore, detonation 
of  carbon-containing  explosives  can  be  used  in  an 
inexpensive synthesis of NDs on a large scale. When 
an oxygen-deficient explosive mixture of trinitrotol-
uene (TNT)/hexogen (RDX) is detonated in a closed 
chamber, NDs are formed at the front of detonation 
wave in a time period of several microseconds. The 
yield of NDs via detonation is crucially dependent on 
the synthesis condition, especially on the heat capac-
ity of the cooling medium (water, air, CO2, etc.) in the 
detonation chamber. The higher the cooling capacity, 
the larger the diamond’s yield will be [1]. These ad-
vantageous properties of NDs have attract extensive 
research interests. 
In fact, as early as in 1963, a high concentration 
of NDs was found for the first time in the smoke after 
the explosion of an explosive named Mixture B used 
by the army. Although it has been studied in the mil-
itary secrecy for a long time, it was not until 1990s that 
NDs have started mass production and been widely 
used in basic researches [1]. At present, a large variety 
of applications for NDs have been proposed, includ-
ing electrochemical coatings, polymer compositions, 
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antifriction coatings, polishing, lubricants, biosensors, 
imaging probes, implant coatings and drug carriers 
[2-8]. Therefore, in view of their widespread applica-
tions and industrial production [1,4,8], it is necessary 
to understand the bio-compatibility of NDs in either 
cell-based systems or animal models. This paper, in its 
first  part,  summarizes  the  main  results  from  the  in 
vitro and in vivo safety assessments of NDs, and fur-
ther points out that NDs can be highly up-taken by 
cells and have good biocompatibility, which are thus 
widely used in the biomedical applications in recent 
years. In the second part of this paper, application of 
NDs in the development of drug delivery systems is 
reported. Finally, an adsorption model for a variety of 
functional  molecules  on  NDs  is  proposed  herein  in 
view of the NDs’ characteristics that it is easy to form 
a porous cluster structure spontaneously in solution 
[9]. This adsorption model provides an outlook of the 
strategies based on NDs for developing a novel smart 
drug  delivery  system  with  the  functional  features 
such as slow-release, targeting, and fluorescence im-
aging,  and  also  contributes  an  important  document 
basis  for  building  drug  delivery  nanosystems  with 
high efficiency and low toxicity. 
The Biocompatibility of Nanodiamonds 
In Vitro Cytotoxicity  
In the carbon nanomaterial safety assessment, in 
vitro cytotoxicity test is an important research subject 
because it is simple, reproducible, and easy to control 
the consistency of experimental conditions. Schrand et 
al. first reported cellular toxicity of NDs through MTT 
assay and ATP production assay and found that NDs 
do not induce significant toxicity on a variety of cells 
[10]. In their follow-up work, they compared the tox-
icity of NDs (with a single-particle size of 2-10 nm), 
carbon  black  (CB),  multi-walled  carbon  nanotubes 
(MWNT),  and  single-walled  carbon  nanotubes 
(SWNT)  on  neuroblastoma  cells  and  macrophages, 
and found that the toxicity follows the order of SWNT 
> MWNT > CB > ND (see figure 1). In addition, the 
macrophage cells were more greatly affected by the 
presence  of  carbon  nanomaterials,  generating  up  to 
five  times  the  amount  of  reactive  oxygen  species 
(ROS) compared with that generated from the neuro-
blastoma  cells  after  exposure  to  either  MWNT  or 
SWNT. However, there was a lack of ROS generation 
from either cell line after incubation with the NDs as 
well as intact mitochondrial membranes, which fur-
ther supported the notion that NDs were of low tox-
icity [11]. Similarly, Liu et al. measured the toxicity of 
NDs and carbon nanotubes (CNTs) on human lung 
A549  epithelial  cells  and  HFL-1  normal  fibroblasts, 
and their results indicated that at the concentration of 
0.1-100 μg/ml, two kinds of carboxyl-modified NDs 
with a particle size of 5 nm and 100 nm respectively 
did not reduce the cell viability or alter the protein 
expression  profile.  In  contrast,  carboxyl-modified 
CNTs exposed under the same conditions showed a 
significant toxicity to the cells. They further compared 
the cytotoxicity of uncarboxylated NDs and CNTs on 
A549 cells, and obtained similar results [12]. Recently 
our group evaluated the biocompatibility of the det-
onation NDs. As consistent with the results reported 
in the literatures, we found that NDs in complete cell 
culture media showed no apparent toxicity on Hela 
cells, and pointed out that the cytotoxicity of NDs was 
highly  related  to  serum  proteins  present  in  the  cell 
culture medium [9]. 
 
 
 
 
Figure 1. Cytotoxicity evaluation after 24 h of incubation with 
various nanocarbons showing differential toxicities on (A) neu-
roblastoma cells or (B) macrophages. Values that are significantly 
different from the control (p<0.05) are denoted with asterisks (*). 
[Reprinted from ref. 11 with permission]. 
 
 
Genotoxicity means that the action of a variety of 
factors in the environment on an organism causes the 
injury of its genetic materials at a chromosome level, a 
molecular level or a base level, resulting in toxic ef-
fects. It is an important subject of the in vitro safety 
assessment of carbon nanoparticles. The chromosomal Theranostics 2012, 2(3) 
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damage caused by interaction between some carbon 
nanoparticles and cells can be self-healing and result 
in  no  genotoxicity  on  the  organism,  whereas  the 
chromosomal or genetic damage caused by other na-
noparticles can be irreversible and result in genotoxi-
city. Huang et al. found no significant change in the 
expression of TNFα and Bcl-x genes after incubation 
with the acid purified NDs compared with controls. 
Additional study of morphological changes and DNA 
fragmentation in macrophages as well as the viability 
of HT-29 human colorectal adenocarcinoma cells re-
vealed a high biocompatibility  of the NDs [7]. Fur-
thermore, Liu et al. incubated A549 lung cancer cells 
and 3T3-L1 embryonic fibroblasts with NDs for a long 
time (10 days), and found that the cell viability was 
not altered. ND particles taken up by cells were al-
most equally separated into two daughter cells of cell 
division,  and  individual  cells  retained  a  single  ND 
cluster in the cytoplasm after sub-cultured for several 
generations.  The  ND  cluster  within  the  cell  didn’t 
induce damages even after a long-term cell culture. 
Moreover,  ND  particles  did  not  interfere  with  the 
gene or protein expressions on the regulation of cell 
cycle progression and adipogenic differentiation of a 
variety  of  cancer  cell  lines.  Therefore,  it  was  con-
cluded that endocytic ND particles are non-cytotoxic 
during cell division and differentiation [13]. However, 
study on the genotoxicity of NDs by Xing et al. gave a 
different result, indicating that incubation of embry-
onic stem cells with NDs led to a slightly increased 
expression  of  DNA  repair  proteins  (p53  and 
MOGG-1)  and  the  oxidized  NDs  (O-NDs)  which 
caused  more  DNA  damage  than  the  pristine/raw 
NDs (R-NDs). This suggests that the chemical groups 
introduced  onto  NDs  by  modification  can  lead  to 
certain  genotoxicity.  However,  compared  with 
MWNT,  the  DNA  damages  caused  by  either  the 
O-NDs or the R-NDs are much less severe [14]. In the 
CNT  cytotoxicity  assessment,  Magrez  et  al.  also 
pointed out that the toxicity of CNTs increased after 
acidic  purification.  In  their  opinion,  grafting  addi-
tional chemical groups such as carbonyl, carboxyl and 
hydroxyl groups, which are putatively “toxic”, onto 
the  surface  of  CNTs  reduced  the  number  of  viable 
cells  [15].  Due  to  the  poor  water-solubility  of  raw 
CNTs, reflux in a concentrated acid is generally re-
quired  before  experiments.  However,  the  raw  NDs 
typically have a good water-solubility even without 
any treatment such as acidic modification. Therefore, 
any oxidative modification of NDs needs to be mini-
mized in the experiment, while keeping the NDs in 
the original form to afford a minimal side effect. 
As a member of carbon nanomaterials, detona-
tion NDs with very small particle sizes tend to form 
aggregates in solution which have a lower surface free 
energy and a particle size of tens to hundreds of na-
nometers. Therefore, they are easily taken up by cells. 
Zhang et al. indicated that in comparison with CNTs 
and graphene, NDs had the highest cellular uptake 
rate [16]. Generally speaking, ND particles were taken 
into  cells  via  a  clathrin-mediated  endocytosis  path-
way [13]. Vaijayanthimala et al. investigated the up-
take mechanism of NDs in the cancer cells (HeLa) and 
pre-adipocytes (3T3-L1) in detail. They also confirmed 
that the uptake of NDs in both cells was through an 
energy-dependent  clathrin-mediated  endocytosis.  In 
addition, the surface charge of ND influences its cel-
lular  uptake,  as  the  uptake  of  poly-L-lysine-coated 
NDs is better than that of oxidative-acid-purified NDs 
at  the  same  concentration.  A  large  number  of  NDs 
into the cells do not affect the in vitro differentiation of 
3T3-L1  pre-adipocytes  and  489-2  osteoprogenitors 
[17]. As can be seen from the in vitro studies, NDs can 
be  highly  up-taken  by  cells  and  show  a  good  bio-
compatibility with a variety of cells. 
In Vivo Toxicity 
In comparison with the in vitro cellular experi-
ment,  the  results  from  the  in  vivo  biocompatibility 
evaluation using animal models can further reflect the 
potential  impact  of  NDs  on  the  environment  and 
human health. NDs from the detonation synthesis are 
in  the  form  of  a  powder  with  a  low  density,  and 
therefore tend to spread into the air during the man-
ufacturing  and  processing  to  cause  environmental 
pollution. Therefore, the study of their toxicity on the 
respiratory  system  is  particularly  important.  In-
tratracheal instillation is an important route to study 
the toxicity of nanoparticles on the respiratory system. 
For the first time, Wang group studied the pulmonary 
toxicity of the NDs administered by intratracheal in-
stillation  in  mice,  and  confirmed  that  NDs  did  not 
have noticeable adverse effects in the lungs within the 
study period according to the histopathological and 
ultrastructural  investigations.  Furthermore,  no  lipid 
peroxidation of the lung was observed. Thus the in-
tratracheally instilled NDs are of low pulmonary tox-
icity. Through the HRTEM images of NDs in the di-
gested pulmonary tissues, they also examined the in 
vivo  distribution  and  translocation  of  NDs  after  in-
tratracheal instillation, and found NDs existed in the 
alveoli and bronchia at different time points. The re-
sults indicated that engulfment by lung macrophages 
might be the most important way to remove NDs [18]. 
Recently, we also studied the acute toxicity of NDs 
administrated  by  intratracheal  instillation,  and  the 
histomorphology  analysis  and  related  biochemical 
indicators showed a dose-dependent toxicity of NDs Theranostics 2012, 2(3) 
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in the lung, liver, kidney and blood [19]. The concen-
trations of NDs used in our experiment were 0.8, 4 
and 20 mg/kg, whereas those in Wang’s experiment 
were 0.1 and 1 mg/kg. The maximum concentration 
of NDs in our experiment was 20 times that in Wang’s 
experiment.  As  can  be  seen,  although  NDs  have  a 
good  biocompatibility,  they  are  still  a  foreign 
non-degradable material for biological organisms and 
may bring the organisms side effects when their ex-
posure concentration exceeds a certain range. How-
ever, the respiratory toxicity of NDs, even under the 
highest dose, on organisms is much smaller than that 
of CNTs and other carbon nanomaterials reported in 
the previous literature [20-22]. 
In addition to intratracheal instillation, Puzyr et 
al.  used  oral  administration  to  study  the  long-term 
toxicity of ND hydrosols on mice and the offspring 
thereof. In their experiment, water in the mice's diet 
was replaced by 0.002 to 0.05 wt.% ND hydrosols for 
three to six months, and the total amount of NDs de-
livered to each mouse was between 16 mg to 450 mg 
depending on the concentration of NDs in hydrosols. 
Their results from comparison with the control mice 
indicated that NDs neither caused death nor affected 
the growth or the internal organ (liver, lungs, heart, 
kidneys,  and  pancreas)  weight  dynamics.  Further-
more,  the  substitution  of  water  with  ND  hydrosols 
did not affect the mouse’s reproductive ability as at 
least the first three generations of the mice consuming 
ND hydrosols since birth had produced healthy off-
spring [23]. In another study, Puzyr et al. further ob-
served no inflammatory symptoms in the mice after 
subcutaneous exposure to NDs for three months [24]. 
Bakowicz  et  al.  reported  that  rats  exhibited  no  im-
mune responses on the tenth day after intraperitoneal 
injection of NDs [25]. It can be seen that NDs admin-
istrated in various routes show good biocompatibility 
with organisms. 
After  introducing  nanomaterials  into  the  body 
by various routes of administration, we need to fur-
ther understand the specific mechanism of their in-
teraction with living systems. The absorption, distri-
bution, metabolism and excretion (ADME) process of 
nanomaterials in the living body is an important basis 
for  studying  the  interaction.  Since  ND  particles  are 
very small, it is difficult to observe their distribution 
in the animal  organs by a conventional microscopy 
method. Radionuclide tracer technique can be appli-
cable to the research in this field due to its easy detec-
tion, high sensitivity, good reliability, and almost no 
outside  interference.  At  present,  various  radionu-
clides such as  99mTc [26,31],  67Ga [27],  125I [28],  111In 
[29], and 64Cu [30] have been used for labeling carbon 
nanoparticles. We used 188Re to label NDs. The labeled 
complex 188Re-ND has a radiochemical purity of more 
than 99% after several days, and is therefore suitable 
for  experimental  research.  Biodistribution  measure-
ment showed that NDs administered by intratracheal 
instillation were distributed mainly in the spleen, liv-
er, bones and heart in addition to the high retention in 
the lung [19]. However, no NDs were found by Wang 
et al. in the mice’s liver, spleen and lymphatic node 
through histopathological and HRTEM observations, 
even when the mice were instilled with a much higher 
dose of 20 mg/kg NDs [18]. This difference may be 
due to different sources of NDs in these two studies. 
More  importantly,  the  in  vivo  distribution  data  ob-
tained  by  us  using  radionuclide  labeling  technique 
show  that  the  distribution  of  NDs  in  the  lung  are 
much  higher  than  that  in  other  tissues  or  organs. 
Therefore,  radionuclide  labeling  technique  is  much 
more sensitive, allowing detection of the information 
that  cannot  be  obtained  by  electron  microscopy.  In 
another work of Wang’s research group, the distribu-
tion of NDs after intravenous injection was studied in 
mice  by  using  125I-labeled  NDs.  The  stability  of 
125I-NDs was greater than 90% within 25 h, and the in 
vivo  distribution  result  showed  that  NDs  predomi-
nantly  accumulated  in  the  liver,  spleen  and  lung. 
About  60%  of  the  injected  NDs  were  found  in  the 
mouse liver at 0.5 h post injection, and the level kept 
constant over 28 days [32]. Rojas et al. labeled NDs 
with  another  radionuclide  18F  to  study  their  in vivo 
biodistribution.  By  positron  emission  tomography, 
they intuitively observed the distribution of the NDs 
administrated  via  intravenous  injection  in  various 
organs of the mice. Their results showed that the NDs 
were mainly distributed in lung, spleen and liver, and 
excreted into the urinary tract. Their research further 
indicated that addition  of surfactant agents did not 
significantly change this distribution pattern, except 
for a slight reduction in the urinary excretion rate. It 
was also found that after removing those NDs with a 
larger  particle  size  by  filtration,  the  uptake  of  NDs 
was completely inhibited in the lung and spleen and 
significantly reduced in the liver (see figure 2) [33]. 
In summary, NDs have no or a small toxic side 
effect on biological systems. Under a different route of 
administration,  the  in  vivo  absorption,  distribution, 
excretion and metabolism of NDs may be different, 
which allows us better understand the risk that NDs 
may pose to human health and provides an important 
basis for designing a ND-based drug delivery system. 
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Figure 2. Coronal sections of PET images acquired 120 min after injection of four different ND preparations. Images show animals 
injected with 18F-NDs dorsal (A) to ventral (B), with filtered 18F-NDs dorsal (C) to ventral (D), with 18F-NDs + Tween 80 dorsal (E) to 
ventral (F), and finally with 18F-NDs + PEG8000 dorsal (G) to ventral (H). Organs that exhibited an elevated uptake of the radiolabeled 
compound are labeled with numbers for easy identification. [Reprinted from ref. 33 with permission]. 
 
 
Application in Drug Delivery Systems 
 Since CNTs and other nanomaterials were dis-
covered, they have been widely applied in the design 
of drug delivery systems because of their small sizes, 
easy  penetration  through  cells,  and  their  special 
structures on the surface which allow a covalent or 
non-covalent bond to the chemicals with poor mem-
brane  permeability  such  as  small  molecule  drugs, 
peptides, protein drugs or DNA [34-38]. Current re-
searches focus on the application of SWNT [35, 38], 
MWNT [34], and graphene [36,37] in drug delivery 
systems. However, many studies have reported that 
the  CNTs  and  graphene  exhibit  some  cytotoxicity, 
induce oxidative stress, and lead to apoptosis or ne-
crosis [39-41]. NDs, as a new member of carbon na-
noparticles  family,  have  emerged  as  an  alternative 
promising  material  for  building  drug  delivery  sys-
tems with high efficiency and low toxicity owing to 
their superior physico-chemical properties and good 
biocompatibility. Currently, NDs are used as a drug 
carrier mainly in two forms: (1) NDs assemble on a 
chemical substrate to form a thin film, having interac-
tions  with  a  drug  in  two-dimension;  (2)  NDs  form 
spontaneous  clusters  also  named  as  ND  hydrogel 
with low free energy in an aqueous solution, having 
interactions with a drug in three-dimension. 
Applications of NDs Film in Drug Delivery Sys-
tems  
The  research  work  on  ND-based  film  to  build 
drug delivery systems has just started, and it is a new 
research field in the application of NDs in medicine. 
In  many  studies,  ND  films  are  prepared  via  a 
self-assembly  process  [42-45],  wherein  the  prepara-
tion method reported by Dean Ho’s research team is 
the simplest method [44]. They deposited ND hydro-
gels onto the poly-lysine (PLL) coated glass substrate 
through self-assembly and controlled the thickness of 
ND-PLL film via a layer-by-layer technique [44]. The 
investigation  of  cellular  gene  expression  as  well  as 
MTT and DNA fragmentation assays revealed that the 
film  has  good  biocompatibility.  Various  biological 
molecules can then assemble on the film (Figure 3). 
The experiment showed that such a self-assembly of 
dexamethasone, which was a kind of glucocorticoid, 
exhibited  obvious  anti-inflammatory  effects  on  the 
RAW264.7  cells,  and  the  dexamethasone  loaded  on 
the  NDs  film  had  a  slow-release  effect.  Therefore, Theranostics 2012, 2(3) 
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their toxic side effects on the normal tissues were ef-
fectively reduced [44]. In another study, NDs bound 
with DOX were embedded in a Parylene C polymer 
microfilm.  The  microfilm  architecture  consists  of 
DOX-ND  conjugates  sandwiched  between  a  base 
layer  of  Parylene  C  and  a  thin  variable  layer  of 
Parylene C, which allows for modulation of drug re-
lease. Due to the powerful sequestration ability of the 
DOX-ND complex and the release-modulating nature 
of the thin Parylene layer, the microfilms displayed 
stable  and  continuous  slow-release  of  drugs  for  at 
least one month. Through DNA fragmentation assays, 
the authors demonstrated that this film retained the 
activity of DOX under biological conditions [46].  
Only  very  few  studies  have  been  reported  on 
building drug delivery systems based on ND films, 
which  may  be  due  to  their  limited  applications  at 
present. A ND-drug film can be implanted immedi-
ately after surgical removal of a tumor to target re-
sidual cancerous cells so as to effectively prevent the 
tumor  from  recurring.  In  addition,  a  ND-drug  film 
can be more applicable to the treatment of superficial 
tumors such as breast cancer, head and neck cancer, 
and  skin  cancer,  or  superficial  skin  inflammations, 
wherein  the  drug  is  delivered  transdermally  to  tu-
mors or inflammation sites, reducing the toxicity on 
normal tissues. 
 
 
 
 
Figure 3. Schematic drawing of the ND-nanofilm formation and 
the drug incorporation into the film. [Reprinted from ref. 44 with 
permission]. 
 
Applications of ND Clusters in Drug Delivery 
Systems  
NDs dispersed in aqueous solution can sponta-
neously form clusters with a lower free energy, also 
named as hydrogel. The clusters have a size of tens to 
hundreds  of  nanometers.  Drug  delivery  systems 
based on such clusters have been reported, wherein 
the  drug  is  loaded  onto  ND  clusters  mainly  in  a 
non-covalent manner. Again, Dean Ho’s group at the 
Northwestern University has done a number of pio-
neering studies. They investigated the adsorption of a 
water-insoluble anti-cancer drug doxorubicin (DOX) 
hydrochloride  [7,  47,  48],  a  protein  kinase  inhibitor 
purvalanol  A  (a  highly  promising  medicament  for 
liver  cancer),  4-hydroxytamoxifen  (a  drug  for  the 
treatment  of  breast  cancer),  anti-inflammatory  drug 
dexamethasone  [49]  and  the  diabetes  drug  insulin 
onto the carrier of ND hydrogel, and also examined 
the  therapeutic  efficacy  of  the  resulting  complexes 
[50]. 
In the preparation of ND-DOX complex, Huang 
et al. found that introducing a small inorganic mole-
cule  NaCl  (10  mg/ml)  to  the  reaction  system  in-
creased the adsorption of DOX on NDs from 0.5 wt% 
to  10  wt%,  and  the  toxicities  of  the  complexes  on 
RAW264.7  mouse  macrophage  and  HT-29  human 
colon cancer cells were less than that of DOX group. 
The authors speculate that the ND aggregates have a 
shielding effect on DOX so that slow release of the 
drug protects normal cells or tissues from side effects 
posed by the drug [7]. They further examined the ef-
ficacy  of  the  NDX  (ND-DOX  complex)  in  mouse 
models of liver cancer and mammary cancer. Biodis-
tribution analysis showed that NDs can be cleared out 
of the body. More importantly, they found that NDX 
overcame the drug efflux from tumor cells, allowing 
anticancer drugs to kill drug-resistant cells at a lower 
dosage,  thus  lowering  the  drug  toxicity  to  normal 
organs and tissues. Gradual release of the drug from 
NDX allowed for increased drug retention in blood 
circulation  and  tumor,  therefore  NDX  significantly 
increased inhibition of apoptosis and tumor growth 
beyond the conventional DOX treatment in both tu-
mor models (Figure 4) [47]. This research work pro-
vides  a  promising  foundation  for  continued 
ND-based  drug  development  and  potential  clinical 
applications [51]. Recently, the same research group 
studied the interaction process between ND clusters 
and DOX, and found that the binding of DOX mole-
cules onto ND occurs only at a high pH and requires 
at least about 10% of the ND surface area to be fully 
titrated for the binding to occur [48]. 
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Figure 4. ND delivery of Dox inhibits tumor growth in murine liver tumor models and mammary carcinoma model. (A) Images of 
livers/tumors from PBS, Dox, ND, or NDX treated LT2-Myc liver tumor bearing mice. (B) Representative images of excised tumors from 
PBS, Dox, or NDX treated 4T1 mammary tumor bearing mice. (C) Kaplan-Meier survival plot for LT2-Myc mice treated with PBS (n = 5), 
Dox (100 mg) (n = 8), or NDX (100 mg of Dox equivalent) (n = 7) by tail vein injection every 7 d. *P < 0.03; **P < 0.06. (D) Kaplan-Meier 
survival plot for 4T1 mice treated with PBS (n = 7), Dox (100 mg) (n = 10), NDX (100 mg of Dox equivalent) (n = 10), Dox (200 mg) (n 
= 5), or NDX (200 mg of Dox equivalent) (n = 5) by tail vein injection every 6 d. *P < 0.003. [Reprinted from ref. 47 with permission]. 
 
In  the  study  of  the  non-covalent  interactions 
between ND with insulin, a pH-dependent desorption 
of the drug from the ND-drug complex was observed. 
In the experiment, NDs were combined with insulin 
at a 4:1 ratio, and exposure of the ND-insulin complex 
to alkaline environments led to a significant release of 
the drug. A 5-day desorption assay in a NaOH (pH 
10.5) solution and a neutral solution resulted in 45.8 ± 
3.8%  and  2.2  ±  1.2%  desorption,  respectively.  MTT 
assays  and  quantitative  RT-PCR  (genes  Ins1  and 
Csf3/G-csf, up-regulated  by insulin stimulation) in-
dicated  that  the  activity  of  insulin  preserved  after 
desorption,  while  the  adsorbed  insulin  remained 
largely inactive. This  work developed a therapeutic 
protein–ND  complex  with  tunable  release  and  pre-
served activity [50]. We recently examined the loading 
of anti-cancer drug 10-hydroxycamptothecin (HCPT) 
on  NDs  and  its  release  therefrom  as  well  as  the 
pharmacodynamics of the complex formed. We found 
that a diluted NaOH solution (pH 8.2) can promote 
the adsorption of HCPT on the NDs and the release of 
HCPT  from  the  complex.  Moreover,  ND-HCPT  in 
slightly  acidic  condition  can  exhibit  a  slow  release 
function,  and  the  efficacy  on  tumor  cells  is  much 
higher than that of free HCPT [9]. A similar study was 
conducted by Guan et al. In the experiment, cisplatin, 
an anticancer drug, was loaded onto NDs by adsorp-
tion. In contrast with the above results, it was released 
from the ND complex in PBS of pH 6.0 at a rate higher 
than in PBS of pH 7.4. Accordingly, the authors spec-Theranostics 2012, 2(3) 
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ulate that the ND vehicle would deliver low concen-
trations  of  cisplatin  in  the  blood,  but  release  much 
more  drugs  after  integration  into  the  acidic  cyto-
plasm,  thereby  reducing  toxic  side  effects.  Further-
more, the drug released from the ND complex retains 
the same cytotoxicity as free cisplatin against human 
cervical  cancer  cells  [52].  As  can  be  seen,  the  drug 
loading and release behaviors of NDs vary because 
the drugs have different physical and chemical prop-
erties. Therefore, to build a drug delivery system, an 
appropriate pH condition needs to be selected to ef-
fectively control the drug adsorption and desorption 
on NDs so as to achieve the best treatment effect. 
In  addition  to  non-covalent  interactions,  other 
studies  reported  that  drug  molecules  were  loaded 
onto the NDs by covalent binding. For example, in 
Li’s experiment, the anti-cancer drug DOX was linked 
to NDs by the reaction between carboxyl groups of 
NDs  and  amine  groups  of  DOX  in  the  presence  of 
EDC and NHS. Furthermore, a cell penetrating pep-
tide TAT was also conjugated to the surface of NDs to 
avoid premature release and to enhance the intracel-
lular  delivery  of  DOX.  Viability  determination 
showed that the ND-TAT-DOX conjugates exhibited a 
higher cytotoxicity to C6 glioma cells than free DOX 
[53]. Liu et al. also used the covalent binding method 
to  develop  another  ND-based  anti-cancer  drug, 
ND-paclitaxel.  Their  results  showed  that  treatment 
with  0.1–50  μg  ml−1  ND-paclitaxel  for  48  h  signifi-
cantly reduced the cell viability in the A549 human 
lung carcinoma cells. ND-paclitaxel was observed to 
induce both mitotic arrest and apoptosis in A549 cells. 
However, ND alone did not induce the damage effects 
on A549 cells. Furthermore, in the in vivo treatment of 
subcutaneous  A549  tumor  xenografted  SCID  mice 
showed that ND-paclitaxel significantly blocked the 
tumor growth [54]. In addition, in some researches to 
build  ND-based  drug  delivery  systems,  NDs  were 
modified  with  some  chemicals  such  as 
N,O-carboxymethyl chitosan [55] and benzoquinone 
[56]  so  as  to  facilitate  non-covalent  interactions  be-
tween  NDs  and  protein  drug  molecules. 
Vaijayanthimala  et  al.  reported  that  some  radia-
tion-damaged  NDs  could  emit  strong  and  stable 
photoluminescence  (red  or  green)  from  nitro-
gen‑vacancy defect centers embedded in the crystal 
lattice  [57].  Low  cytotoxicity  and  no  sign  of  photo-
bleaching  were  found  for  these  NDs,  making  them 
well-suited for long-term tracking of a single ND par-
ticle in live cells [4,58,59]. These functionalized fluo-
rescent  NDs  may  serve  as  both  an  imaging  system 
and a drug delivery system for theranostic applica-
tions.  
Covalent  manner  and  non-covalent  manner  of 
building ND-based drug delivery systems have their 
advantages  and  disadvantages.  A  stable  drug  com-
plex  can  be  obtained  in  a  covalent  manner,  but  its 
manufacture process is complicated, and moreover it 
is  difficult  to  remove  all  the  toxic  organic  solvents 
introduced during the synthesis process. In addition, 
the  drug  complex  prepared  in  this  manner  usually 
does not have the slow-release function. In contrast, 
although the drug bound to NDs in a non-covalent 
manner does not have high stability, the preparation 
method is simple and easy, and more importantly, the 
drug loading can be adjusted by simply controlling 
some inorganic molecules such as NaOH and NaCl. 
The  drug  complex  into  the  cells  does  have  a 
slow-release function, reducing the side effects of the 
drug itself. Therefore, a majority of basic researches at 
present  choose  the  non-covalent  method  to  build 
ND-based drug delivery systems. 
Perspectives 
The  characteristics  of  NDs,  such  as  optical 
transparency,  chemical  inertness,  high  specific  area, 
robust hardness and excellent bio-compatibility, have 
provided  a  series  of  promising  results  in  basic  re-
searches in the field of medicine. However, it should 
be noted that, like other nanomaterials such as CNTs 
and graphene [60-65], due to a large surface area and 
high adsorption capacity, the high adsorption of var-
ious  components  in  the  environmental  media  onto 
NDs may affect their inherent biological effects. It has 
been found that the NDs might be either nontoxic or 
toxic to cells, depending on whether serum existed in 
the  culture  medium  or  not.  The  possible  toxicity 
mechanisms associated with serum proteins and ex-
cessive sodium ions delivered into cells by NDs are 
under further investigation [9]. Therefore, when we 
build  ND-based  drug  delivery  systems,  particular 
attention should be paid to the impact of proteins and 
ions in the solution on the pharmaceutical efficacy. 
 Low toxicity and high cellular uptake of NDs in 
complete cell culture media [9, 16] make them an ideal 
carrier for building drug delivery systems. However, 
most of the current ND-drug complexes are built as a 
binary  complex  system  of  the  NDs  and  the  drug 
molecule.  Unlike  CNTs,  it  has  been  rarely  reported 
that NDs are simultaneously modified with fluores-
cent molecules, targeting molecules, and drug mole-
cules to build a multi-functional drug. This is due to 
the  nature  of  the  NDs  themselves.  Detonation  NDs 
comprise  diamond  micro-grains  with  2-8  nm  in  di-
ameter, and the surface area of a single ND is not as 
large as that of a single CNT. A single ND also does 
not  have  high  chemical  activity  or  strong 
non-covalent  interaction  with  other  chemicals  as  a Theranostics 2012, 2(3) 
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single CNT does. However, because of its high surface 
free energy, NDs rarely exist in a single particle, and 
usually form clusters of tens to hundreds nanometers 
in a low free energy, even when they are dispersed in 
a solution by strong ultrasonication. Since NDs have a 
very high hardness and nanoscale pores exist among 
individual  particles  in  the  ND  clusters,  drug  mole-
cules or other functional molecules can be assembled 
on the surface of ND clusters or in these nano-scaled 
pores in the interior of ND clusters by non-covalent 
interactions. Various surface or internal distribution 
of drug molecules or other functional molecules with 
different sizes can be expected for the ND clusters. 
Based on the existing studies of the assembly process 
of several different molecules on ND clusters, a model 
for the spatial configuration of ND clusters and their 
assembly  process  has  been  proposed  [9]  (figure  5). 
According  to  this  scheme,  we  have  succeeded  in 
loading  fluorescein-  isothiocyanate  (FITC),  HCPT, 
and transferrin (TF) onto ND clusters in the order of 
these  molecules’  sizes,  which  is  built  into  a  drug 
(HCPT) delivery system with drug activity, fluores-
cence  function  and  targeting  function.  Such  a  drug 
delivery system opens up new ideas for the further 
development of novel ND-based smart drugs which 
are desirable for their versatility, high efficiency, and 
low toxicity. 
 
 
 
 
 
 
Figure 5. Schematic illustration showing the different loading of 
different functional molecules on NDs. 
 
 
Furthermore, the assembly mechanism of vari-
ous  functional  molecules  such  as  imaging  agents, 
drugs and targeting  molecules on NDs needs to be 
studied  through  interdisciplinary  researches  involv-
ing chemistry, physics, materials, biology and medi-
cine. The investigation of the assembly principles and 
characteristics  of  different  functional  molecules  on 
NDs would help to establish the models and theories 
for  building  ND-based  versatile  drug  delivery  sys-
tems, which would serve as the basis for developing a 
variety of ND-based drug delivery systems with high 
efficiency  and  low  toxicity  to  prevent  and/or  treat 
various cancers.  
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